Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


FORM 8-K

 


Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (date of earliest event reported): January 25, 2007

 


MILLENNIUM CHEMICALS INC.

(Exact name of registrant as specified in its charter)

 


Delaware

(State or other jurisdiction of incorporation)

 

1-12091   22-3436215
(Commission File Number)   (I.R.S. Employer Identification No.)

 

Two Greenville Crossing, 4001 Kennett Pike,

Suite 238 Greenville, Delaware

  19807
(Address of principal executive offices)   (Zip Code)

(713) 652-7200

(Registrant’s telephone number, including area code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 2.02 Results of Operations and Financial Condition

On January 25, 2007, Lyondell Chemical Company (“Lyondell”) issued a press release announcing Lyondell’s, Equistar Chemicals, LP’s (“Equistar”) and Millennium Chemicals Inc.’s (“Millennium”) results for the fourth-quarter and full-year of 2006, which is furnished herewith as Exhibit 99.1 and incorporated by reference into this Item 2.02. As a result of Lyondell’s November 30, 2004 acquisition of Millennium, Equistar and Millennium are wholly owned subsidiaries of Lyondell.

Lyondell will host a conference call on January 25, 2007 at 11:30 a.m. Eastern Time to discuss the results. The call will be broadcast live on Lyondell’s web site at www.lyondell.com/earnings. A replay of the call will be available on the web site at www.lyondell.com/earnings at 2:30 p.m. Eastern Time on January 25, 2007. Reconciliations of non-GAAP financial measures to GAAP financial measures, together with any other applicable disclosures, including the earnings release, will be available at 11:30 a.m. Eastern Time on January 25, 2007 at www.lyondell.com/earnings.

Item 9.01 Financial Statements and Exhibits

 

  (c) Exhibits.

 

  99.1 Press Release (furnished as Exhibit 99.1 to Lyondell’s Current Report on Form 8-K dated as of January 25, 2007 and incorporated herein by reference)

 

2


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

MILLENNIUM CHEMICALS INC.
By:  

/s/ Kerry A. Galvin

Name:   Kerry A. Galvin
Title:   Senior Vice President and
  General Counsel
 

Date: January 25, 2007


INDEX TO EXHIBITS

 

Exhibit
Number
  

Description

99.1   

Press Release (furnished as Exhibit 99.1 to Lyondell’s Current Report on Form 8-K dated as of January 25, 2007 and

incorporated herein by reference)